Nitrosamine Compliance: Regulatory Requirements from Risk Assessments to Control Strategies

Nitrosamine guidelines have touched every aspect of the pharmaceutical industry. In this webinar, we will cover the full scope of regulatory expectations. We will address expectations and tips for those who are writing the initial risk assessments, performing method development, investigating how a nitrosamine is formed, or defining the strategy to ensure lasting compliance.
Presenter: Dr. Jason Brown Ph.D
Jason Brown is an experienced end to end nitrosamine expert, designing and leading the multi year effort to global regulatory compliance for a global CDMO and their business partners. Showcasing, proven knowledge in risk assessments, structural identification, analytical techniques, root cause analysis, reformulation, and control strategies, Jason has, authored a July 2025 AAPS Newsmagazine Cover Article, "Nitrosamine Control Strategies: From Risk Identification to Implementation.“ He is a recognized innovator with a patent application for reformulation strategies along with articles concerning inhibition techniques and gastric nitrosamine formation.
